Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response.

Radiology
Keiko MiyazakiDow-Mu Koh

Abstract

To evaluate dynamic contrast-enhanced (DCE) magnetic resonance (MR) imaging for monitoring and assessing treatment response in patients with neuroendocrine liver metastases treated using yttrium 90 ((90)Y)-labeled octreotide ((90)Y-DOTATOC). The study was approved by the local research and ethics committee and patient informed consent was obtained. Twenty patients with liver metastases from neuroendocrine tumors underwent T1-weighted DCE MR imaging of the liver before and at 2 months after intravenous (90)Y-DOTATOC treatment. Regions of interest were drawn around target lesions, as well as along liver outlines for each patient. A dual-input single-compartment model was used to compute parameters including fractional distribution volume and the arterial flow fraction. Pre- and posttreatment values were compared using Wilcoxon signed rank test. Treatment response was defined as showing a greater than 50% reduction in the nadir chromogranin A level within the 1st year after treatment. Pretreatment values of responders and nonresponders were compared using the Mann-Whitney test. A two-tailed P value of .008 or less, which accounts for multiple testing, was considered to indicate a significant difference. In responders, tumor and wh...Continue Reading

References

Jan 1, 1987·Magnetic Resonance Imaging·E K FramN J Pelc
Jul 10, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E P KrenningR Valkema
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph P EderDonald W Kufe
Jun 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan M GalbraithGordon J S Rustin
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James P StevensonPeter J O'Dwyer
Feb 15, 2005·The Oncologist·Johanna M Zuetenhorst, Babs G Taal
Oct 19, 2005·Investigative Radiology·Martin RohrerHanns-Joachim Weinmann
Mar 22, 2006·Radiographics : a Review Publication of the Radiological Society of North America, Inc·James A d'ArcyMartin O Leach
Oct 13, 2006·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Geoff J M ParkerGordon C Jayson
Feb 26, 2008·Physics in Medicine and Biology·Matthew R OrtonMartin O Leach
Mar 19, 2009·Physics in Medicine and Biology·Matthew R OrtonMartin O Leach
May 28, 2009·Journal of Magnetic Resonance Imaging : JMRI·Simon BaxterBenjamin M Yeh
Jun 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W R JarnaginN Kemeny
Mar 11, 2010·Annals of Surgical Oncology·Irvin M ModlinMark Kidd

❮ Previous
Next ❯

Citations

May 9, 2012·European Radiology·M O LeachUNKNOWN Experimental Cancer Medicine Centres Imaging Network Steering Committee
Apr 4, 2014·World Journal of Gastroenterology : WJG·Bang-Bin Chen, Tiffany Ting-Fang Shih
Aug 5, 2014·Magnetic Resonance Imaging Clinics of North America·Celia Pamela Corona-VillalobosIhab R Kamel
Aug 5, 2014·Magnetic Resonance Imaging Clinics of North America·Choon Hua ThngDow-Mu Koh
Oct 11, 2013·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Fernanda D Gonzalez-GuindaliniVahid Yaghmai
Dec 18, 2013·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Livia BernardinNandita M Desouza
Feb 12, 2013·Seminars in Ultrasound, CT, and MR·Vicky GohDow-Mu Koh
Nov 29, 2015·Magnetic Resonance Imaging Clinics of North America·Antonio LunaVikas Gulani
Oct 5, 2015·Cancer Metastasis Reviews·Rocio Garcia-CarboneroUNKNOWN Spanish Cooperative Group of Neuroendocrine Tumors (GETNE)
Oct 19, 2016·Journal of Hepatology·Maxime RonotAndrea Frilling
Jun 23, 2019·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Matteo IppolitiChristoph Kolbitsch
Apr 19, 2017·Oncotarget·Yuling YanBaozhong Shen
Mar 23, 2018·Scientific Reports·Shivani PahwaVikas Gulani
Jul 31, 2019·Journal of Thyroid Research·Sergiy V KushchayevOleg M Teytelboym
Jun 17, 2015·World Journal of Gastroenterology : WJG·Riccardo De RobertisMirko D'Onofrio
May 26, 2020·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Neal BhutianiRobert C G Martin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved